Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Tobacco Use Disorder 1Squamous Cell Carcinoma of Head and Neck 1Overweight 1Obesity 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Cancer Survivor 1Breast Neoplasms 1

Interventions

Counseling 5Nutrition Assessment 4Exercise 4Methods 3Diet Therapy 3Caloric Restriction 3Educational Status 2Early Intervention, Educational 2Diet 2Cognitive Behavioral Therapy 2drospirenone and ethinyl estradiol combination 1drospirenone 1Trehalase 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Sugars 1Sucrose 1Standard of Care 1Resistance Training 1Psychology, Positive 1Patient Navigation 1Naltrexone 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Flutamide 1Ethinyl Estradiol 1Diet, Vegetarian 1Diet, Vegan 1Diet, Mediterranean 1Diet, Healthy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Overweight × Bupropion × Clear all
NCT03581630 2018-08-29

Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer Patients

Gangnam Severance Hospital

Phase NA Completed
72 enrolled
BreastOther

Breast Neoplasms, Obesity, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡